Niacin News and Research

RSS
Niacin (also known as vitamin B3, nicotinic acid and vitamin PP) is an organic compound with the formula C5H4NCO2H and, depending on the definition used, one of the between forty to eighty essential human nutrients.
FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD

FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD

MRI scans may become useful tools for assessing cholesterol drugs

MRI scans may become useful tools for assessing cholesterol drugs

Merck receives FDA approval for JUVISYNC to treat type 2 diabetes

Merck receives FDA approval for JUVISYNC to treat type 2 diabetes

Increasing levels of 'good' cholesterol reduces risk for heart attack and stroke among diabetics

Increasing levels of 'good' cholesterol reduces risk for heart attack and stroke among diabetics

The Polyclinic participates in major international HDL clinical research study

The Polyclinic participates in major international HDL clinical research study

UVB light processing boosts vitamin D in mushrooms

UVB light processing boosts vitamin D in mushrooms

EAS/ESC develops new dyslipidaemias guidelines

EAS/ESC develops new dyslipidaemias guidelines

Localized one-time gene therapy might effectively protect against atherosclerosis

Localized one-time gene therapy might effectively protect against atherosclerosis

Cornell grants ChromaDex worldwide rights to novel manufacturing process for nicotinamide riboside

Cornell grants ChromaDex worldwide rights to novel manufacturing process for nicotinamide riboside

EAS, ESC develop new European guidelines to manage dyslipidaemias

EAS, ESC develop new European guidelines to manage dyslipidaemias

Maternal smoking 'imprints' unhealthy set of characteristics on unborn babies

Maternal smoking 'imprints' unhealthy set of characteristics on unborn babies

New anti-abuse formulation of painkiller Oxycodone

New anti-abuse formulation of painkiller Oxycodone

Larger trial study needed to decide fate of niacin

Larger trial study needed to decide fate of niacin

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

U.S. FDA announces safety label changes for cholesterol-lowering medication, simvastatin

U.S. FDA announces safety label changes for cholesterol-lowering medication, simvastatin

Cholesterol drug Niaspan fails to protect heart: Study

Cholesterol drug Niaspan fails to protect heart: Study

Efficacy of Abbott cholesterol drug in question

Efficacy of Abbott cholesterol drug in question

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

New autism research findings presented at 10th annual IMFAR

New autism research findings presented at 10th annual IMFAR